Advisers to the Food and Drug Administration voted unanimously Friday to recommend the agency authorize an extra dose of Johnson & Johnson’s Covid-19 vaccine, to shore up protection against the coronavirus. The panel of outside doctors and experts voted 19-0 to recommend that all adults who received a first dose of the J&J vaccine should get the second…

The healthcare company said Thursday that a corporate affiliate holding talc-related liabilities had filed for chapter 11 protection “to resolve all claims related to cosmetic talc in a manner that is equitable to all parties, including any current and future claimants.” The chapter 11 filing makes J&J the latest company to turn to chapter 11…

A booster of Johnson & Johnson’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, federal health regulators said Wednesday. The regulators cautioned, however, that data was limited and they had to rely on J&J’s own analysis for some of the study findings, rather than conducting their own. The Food and Drug…

Johnson & Johnson said Tuesday that the company had submitted data to the Food and Drug Administration to support the use of a booster dose of its Covid-19 vaccine. The announcement comes two weeks after the company presented the results of a randomized, controlled Phase 3 study showing that a booster dose given two months after…

Data released Tuesday from a late-stage clinical trial showed that study participants in 10 countries including the U.S. who received a second dose of the company’s vaccine two months after the first had 75% protection against symptomatic Covid-19. Participants in the U.S. had 94% protection against the illness. J&J didn’t explain the reason for the…